Insider · CIK 0001690576
Firdaus J. Dastoor
Files at XBIO (Xenetic Biosciences, Inc.). First filing -, latest -.
Firdaus J. Dastoor files SEC Form 4 as director at XBIO (Xenetic Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Firdaus J. Dastoor has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | XBIO Xenetic Biosciences, Inc. | AGrant or award Stock Optionsderivative | +2,500 | $0.00 | $0 | 2,500 | Jan 5, 2026 |
| Dec 11, 2024 | XBIO Xenetic Biosciences, Inc. | AGrant or award Stock Optionsderivative | +2,500 | $0.00 | $0 | 2,500 | Dec 13, 2024 |
Questions about Firdaus J. Dastoor
Answered from the filings on this page, as of the latest one.
Is Firdaus J. Dastoor buying or selling?
Firdaus J. Dastoor has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Firdaus J. Dastoor's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Firdaus J. Dastoor has 0.
Where does Firdaus J. Dastoor file Form 4?
Firdaus J. Dastoor has filed Form 4 at XBIO (Xenetic Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.